Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Photoprotective Technologies, Inc.’s MPF™ Lenses Tackle Prenatal Health and Postpartum Depression Caused By Sleep Loss
  • USA - English


News provided by

Photoprotective Technologies Incorporated

Jan 11, 2018, 03:00 ET

Share this article

Share toX

Share this article

Share toX

PPT offers a non-invasive option to promote wellness during and after pregnancy that does not involve taking melatonin supplements which fall outside of FDA regulation.
PPT offers a non-invasive option to promote wellness during and after pregnancy that does not involve taking melatonin supplements which fall outside of FDA regulation.

MPF™ lenses with melanin represent an optimization by PPT wherein the melanin was modified to maximize the filtration of the portion of the blue light that caused the greatest suppression of melatonin while still preserving color perception when compared to other lenses

Post this

SAN ANTONIO (PRWEB) January 11, 2018 -- Texas-based Photoprotective Technologies (PPT) Incorporated, a world leader in blue light filtration technology, leverages their Melatonin Production Factor (MPF™) lenses to promote a common underlying factor associated with positive prenatal, neonatal, and postpartum health. Using melanin as a natural way to filter harmful light, MPF™ lenses have been shown to disrupt the suppression of the vital hormone Melatonin. Commonly referred to as the sleep hormone, Melatonin has an important role in all stages of reproduction, from fertility to post-partum recovery. By offering lenses in frames designed specifically for women, PPT hopes to promote usage of blue light blocking glasses that offer a significant gain in overall wellness.

Decades of research has long established that melatonin does more than just help us fall asleep at night (1). Melatonin is thought to play a critical role in reproductive health and numerous studies have proven it plays an essential role as an important regulator of the complex embryo-fetal developmental processes (2). Melatonin readily crosses the placenta and the fetal blood-brain barrier, and during a normal pregnancy, acts as an antioxidant and is essential for a successful pregnancy and post-partum health (2). Primarily, melatonin induces the circadian rhythmicity in the developing fetus that carries through to after the birth and appears to have a direct developmental effect on nervous and endocrine system (2). There is solid evidence that melatonin is neuroprotective and has a positive effect on the outcome of high risk pregnancies (2). Compromised pregnancies result in oxidative stress to the fetus and alter fetal development, but melatonin can protect organs in development from damage due oxidative stress. Most amazingly, in small neonatal clinical studies, melatonin improved outcomes in sepsis, prematurity and perinatal asphyxia (3) After giving birth, as any parent can tell you, sleep is disrupted which in turn disrupts the circadian rhythm. Researchers are currently conducting studies to correlate the levels of melatonin to rates of postpartum depression to single out one of the many factors that contribute to the disorder commonly experienced by so many women.

Using MPF™ lenses to preserve the production of Melatonin caused by evening exposure to certain wavelengths of light, PPT offers a non-invasive option to promote wellness during and after pregnancy that does not involve taking melatonin supplements which fall outside of FDA regulation. High energy visible light, commonly referred to as blue light, is the main culprit behind the suppression of night time production of melatonin. Blue light, which is particularly beneficial during the daytime, is more disruptive at night, and induces the strongest melatonin inhibition. Nocturnal blue light exposure is increasing due to the growing dependence on cellphones, tablets, LED screens and energy-efficient lightbulbs. PPT has set the bar for lenses that preserve the production of Melatonin when it developed the patent-pending Melatonin Production Factor™ (MPF™) rating for lenses that should become an industry standard for rating blue light blocking glasses. PPT distinguishes itself from other manufactures of blue light blocking lenses by using melanin as the basis for its light filtration technology. Found in the eyes, hair and skin, melanin is the body’s natural defense against harmful light. "MPF™ lenses with melanin represent an optimization by PPT wherein the melanin was modified to maximize the filtration of the portion of the blue light that caused the greatest suppression of melatonin while still preserving color perception when compared to other lenses," according to physicist Dr. James Gallas, CEO of PPT and inventor of melanin lenses.

Adding to its very popular offerings of unisex frames with MPF™ lenses, http://www.mpf6.com will now offer women an option to purchase frames that are specifically designed to offer maximum comfort and complement the feminine facial structure. PPT also feels strongly about protecting children's vision from blue light damage and lends its technology and support to Melakids, TrueBlue, BLUTECH, and, ESP Eyewear .

Sources:
(1) Physiology (Bethesda). 2014 Sep;29(5):325-33. doi: 10.1152/physiol.00011.2014. Melatonin: exceeding expectations. Reiter RJ1, Tan DX2, Galano A3.
(2) J Med Life. 2014 Oct-Dec; 7(4): 488–492. Role of melatonin in embryo fetal development SE Voiculescu,* N Zygouropoulos,* CD Zahiu,* and AM Zagrean.
(3) J Pineal Res. 2009 Mar;46(2):128-39. doi: 10.1111/j.1600-079X.2008.00649.x. Epub 2008 Nov 19. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. Gitto E1, Pellegrino S, Gitto P, Barberi I, Reiter RJ.

Trevor Lemon, Photoprotective Technologies Incorporated, http://www.mpf6.com, +1 (210) 493-6353, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.